Compare Merck & Co., Inc. (MRK) vs Global X Robo Global Robotics & Automation ETF (ROBO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Global X Robo Global Robotics & Automation ETF — how do they compare? Merck & Co., Inc. trades at $126.26 (market cap $307.25B), while Global X Robo Global Robotics & Automation ETF trades at $79.51. The key difference: Merck & Co., Inc. pays a 2.73% dividend while Global X Robo Global Robotics & Automation ETF pays none, and Merck & Co., Inc. is trading nearer its 52-week high, Global X Robo Global Robotics & Automation ETF nearer its low. Which is the better fit depends on your goals.
| MRK | ROBO | |
|---|---|---|
Market Cap | $307.25B | — |
Sector | Health | Sector/Thematic |
52-Week High | $129.52 | $90.34 |
52-Week Low | $77.60 | $61.34 |
Enterprise Value | $350.66B | — |
Dividend Yield | 2.73% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $126.27, down 0.96% on the day, with a neutral technical signal and strong fundamental performance. The company reported robust 2025 results with $65.01B revenue and $18.25B net income, beating EPS estimates in recent quarters. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, while analyst consensus remains bullish with a $137.30 price target.
Outlook is positive driven by earnings momentum and strategic M&A, but risks include patent expirations and competitive pressures. The stock offers a dividend yield with upcoming payment, supporting income investors. Valuation multiples are elevated, requiring sustained growth to justify current levels amid macroeconomic uncertainties.
ROBO trades at $77.31, down 0.74% today, with a bearish technical signal from moving averages but bullish oscillators. Recent news highlights robotics as the next AI investment wave, with ROBO positioned in physical automation. Financial ratios are unavailable, but thematic ETF inflows suggest growing investor interest in robotics and AI infrastructure.
Outlook is cautiously optimistic due to AI-driven demand for robotics, though cyclical exposure and valuation concerns pose risks. The ETF's diversification across machinery and electronics offers growth potential, but investors should monitor earnings momentum and sector rotation trends for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Global X Robo Global Robotics & Automation ETF
ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.
Read more on ROBO →
